Table 2.

Association between DEP gene signature and MEP concentration in pre-malignant adjacent breast tissues (p < 0.05) among LIBCSP case women.

All (n = 294)	P-value	Beta	Postmenopausal (n = 189)	P-value	Beta	Postmenopausal with high AR expression (n = 167)	P-value	Beta	Premenopausal (n = 99)	P-value	Beta
AREG	0.014	−0.14	AREG	0	−0.22	AREG	0	−0.244	HMGCS2	0.006	0.41
TMEM50B	0.026	0.07	TMC4	0.008	−0.23	SLC5A3	0.002	0.124	CLDN8	0.023	0.26
CA8	0.03	−0.11	TMEM50B	0.008	0.11	SPINT1	0.008	−0.117	MUC1	0.039	0.22
C4ORF19	0.045	0.13	MPZL3	0.013	−0.17	NAT8L	0.01	0.262
			P4HA1	0.014	−0.18	TSPAN1	0.011	−0.284
			CA8	0.015	−0.16	P4HA1	0.015	−0.186
			SLC5A3	0.034	0.09	TACSTD2	0.015	−0.137
			PLEKHA6	0.039	−0.15	TMC4	0.016	−0.22
			NAT8L	0.045	0.20	CA8	0.021	−0.16
						SLC44A4	0.022	−0.238
						FXYD3	0.023	−0.125
						MPZL3	0.032	−0.153
						KRT18	0.036	−0.098
						PLEKHA6	0.037	−0.161
						TMEM50B	0.039	0.075